I dont need to stay home, Im not embarrassed, Im already looking forward to summer
Lawsuits are being filed against Novo Nordisk, the manufacturer of Wegovy, by affected patients and their families
Learn: - The usual amount of lean mass loss during weight loss - How much was lost in small subset using semaglutide and tirzepatide - What is the clinical relevance - and more
To summarise, when prescribing a treatment, clinicians should consider injection device preference as well as the efficacy, safety and other important treatment attributes
Furthermore, their use may be limited by the requirement for injections, thereby limiting patient adherence and acceptance
Patients often achieve a 15 to 20 percent reduction in body weight